Cyfendus Anthrax Vaccine Wins FDA Approval
XTalks
JULY 25, 2023
Kelly Warfield, Emergent’s senior vice president, science and development, in the company’s press release. Anthrax is a rare, yet severe disease caused by the bacterium B. Cyfendus functions by stimulating the production of antibodies targeted against the protective antigen protein. What Is Anthrax?
Let's personalize your content